| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | Chief Commercial Officer | Sep 16, 2025 | |||
| ICPT | INTERCEPT PHARMACEUTICALS, INC. | EVP & Chief Commercial Officer | Nov 8, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|